PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSO100200700032CModification 12 — Biocryst Pharmaceuticals, Inc

Biocryst Pharmaceuticals, Inc holds $-26,665,936 across 20 federal awards. Competition previously drew 7 offers. Set-aside status: NONE. PoP ended Apr 30, 2014 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Biocryst Pharmaceuticals, Inc

Recipient

Apr 30, 2014

PoP end

$-29,867,448.05

Obligated

541710

NAICS

AN13

PSC

NONE

Set-aside

7 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Biocryst Pharmaceuticals, Inc — $90

Contract facts

NONE

Contract numberHHSO100200700032C

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentBiocryst Pharmaceuticals, Inc

UEIMGXADJ6SCLJ5

NAICS541710

No full NAICS 541710 intel page yet. Browse NAICS intelligence

PSCAN13

Place of performanceBIRMINGHAM, AL

Related solicitationDHSORDCVB0601

PoP end (current)Apr 30, 2014

Obligated$-29,867,448.05

MODIFICATION 12 is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Biocryst Pharmaceuticals, Inc. Estimated value $205.3M ($-29,867,448.05 obligated). Current period of performance ends Apr 30, 2014. Last award drew 7 bidders. Place of performance: BIRMINGHAM, AL. Related solicitation DHSORDCVB0601.

Recompete timing

Public

● Past PoP end (4505 days ago)

Current PoP ended Apr 30, 2014 (4505 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Biocryst Pharmaceuticals, Inc — $-26,665,936 obligated across 20 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$1.6M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HHSO100200700032C?

HHSO100200700032C (Modification 12) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $205.3M, currently held by Biocryst Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HHSO100200700032C?

Barda - Aspr / Daappo / Barda Dcma awarded HHSO100200700032C to Biocryst Pharmaceuticals, Inc.

Who is the incumbent on HHSO100200700032C?

Biocryst Pharmaceuticals, Inc is the incumbent with $-26,665,936 across 20 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2014.

When does Biocryst Pharmaceuticals, Inc’s HHSO100200700032C come up for recompete?

SCOUT tracks a period-of-performance end of Apr 30, 2014. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HHSO100200700032C — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jan 10, 2025